The fall flurry of biotech IPOs shows no signs of abating, with Upstream Bio becoming the latest company to express an intention to go public. The Waltham, Massachusetts-based biotech has yet to set ...

Officials at Cytiva and Culture Biosciences say the companies are collaborating to advance innovation in upstream bioprocessing by providing customers greater access to predictive and robust scale-up ...

Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest biotechs to list on the Nasdaq. Upstream had previously expected to sell 12 ...

New K-NIBRT training hub addresses South Korea's critical biotech workforce shortage, graduating 3,400+ students in 2025 to ...